Sun Pharma Establishes $2.5 Million Dermatology Professorship at Mount Sinai
Key Takeaways
- Sun Pharma established the Sun Professorship in Dermatology at the Icahn School of Medicine at Mount Sinai through a $2.5 million endowment.
- Mark G. Lebwohl, MD, was named the professorship’s inaugural holder, recognizing his work in psoriasis, inflammatory skin disease, clinical therapeutics, and dermatology education.
- The endowed position is intended to provide long-term support for dermatology research, training, and academic leadership at Mount Sinai.
Sun Pharma has established an endowed dermatology professorship at the Icahn School of Medicine at Mount Sinai, naming longtime psoriasis researcher and academic dermatologist Mark G. Lebwohl, MD, as its inaugural holder.
Supported by a $2.5 million endowment from Sun Pharma, the Sun Professorship in Dermatology will be based within the Kimberly and Eric J. Waldman Department of Dermatology. According to the announcement, the permanent endowment will support academic leadership, research, and training in dermatology.
Sun Professorship Recognizes Dr. Lebwohl’s Contributions to Dermatology
Dr. Lebwohl serves as Dean for Clinical Therapeutics at the Icahn School of Medicine at Mount Sinai and Professor and Chairman Emeritus of the Kimberly and Eric J. Waldman Department of Dermatology. His work has focused extensively on psoriasis and other inflammatory skin diseases, including clinical research that has contributed to advances in treatment.
Dr. Lebwohl also is Chairman Emeritus of the Medical Board of the National Psoriasis Foundation and served as president of the American Academy of Dermatology from 2015 to 2016.
“The greatest value of this professorship is the opportunity it creates to pursue important questions, support promising investigators and help turn scientific advances into better care for patients,” Dr. Lebwohl said in the announcement.
Emma Guttman, MD, PhD, Waldman Professor and System Chair of the department, said the endowment reflects a shared investment in scientific and academic leadership as dermatology continues to evolve.
“Dermatology has undergone a remarkable transformation over the past several decades and continued progress depends on supporting the next generation of clinicians, investigators and innovators,” Dr. Guttman said.